These findings suggest that ATRA can be used to treat APL patients with NPM/RAR as well as APL with PML/RAR..     ///    We describe a 64-year-old man with NPM-RAR-positive APL who was receiving hemodialysis therapy for chronic uremia.     ///    Successful all-trans retinoic acid treatment of acute promyelocytic leukemia in a patient with NPM/RAR fusion.. 